Meeting
2023 ASCO Annual Meeting
Real-world treatment patterns and clinical outcomes among subgroups of BRAF-positive metastatic melanoma patients treated with dabrafenib + trametinib.
Authors
Zeynep Eroglu
H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
Zeynep Eroglu , Jackson Tang , Clare Byrne , Lucy Connolly , Rohan Shah , Thach-Giao Truong
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Melanoma/Skin Cancers
Track
Melanoma/Skin Cancers
Sub Track
Advanced/Metastatic Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 9521)
DOI
10.1200/JCO.2023.41.16_suppl.9521
Abstract #
9521
Poster Bd #
284
Abstract Disclosures
Similar Posters
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Real world treatment patterns of first-line combination therapies among BRAF+ metastatic melanoma patients stratified by tumor burden.
First Author: Sameer Ghate
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Real-world treatment patterns, testing patterns, and clinical outcomes of first-line (1L) therapy for metastatic gastric cancer, gastroesophageal junction cancer, or esophageal adenocarcinoma (mGC/GEJC/EAC).
First Author: Sumie Kakehi
Poster
2020 Genitourinary Cancers Symposium
A multicenter retrospective study to evaluate real-world clinical outcomes in patients with metastatic renal cell carcinoma (mRCC) and brain metastasis treated with ipilimumab and nivolumab.
First Author: Landon Carter Brown
Poster
2019 Gastrointestinal Cancers Symposium
Real-world treatment patterns and clinical outcomes in patients receiving second-line (2L) treatment for advanced or metastatic gastric cancer (GC).
First Author: Mayur Amonkar